Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Hormonal Depression due to Treatment of Animals with Chlorpromazine

Abstract

IN an earlier paper, we have shown that in human patients chlorpromazine impairs the hypothalamus and through it the anterior pituitary lobe1. This depressing effect balances itself in accordance with the push–pull principle so far as the following tropins are concerned: follicle-stimulating hormone, luteinizing hormone, adrenocorticotropic hormone and thyroid-stimulating hormone, since they produce secondary hormones. This is impossible, however, with regard to luteotropic hormone and somatotrophic hormone, as neither of them produces peripheral secondary hormones.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Sulman, F. G., and Winnik, H. Z., Lancet, i, 161 (1956).

  2. Winnik, H. Z., and Tennenbaum, L., Presse méd., 63, 1092 (1955).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

SULMAN, F., WINNIK, H. Hormonal Depression due to Treatment of Animals with Chlorpromazine. Nature 178, 365 (1956). https://doi.org/10.1038/178365a0

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/178365a0

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing